arrow
S

Steven C. Clifford

wolfson childhood cancer research centre
H指数:62
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Strategic roadmap for delivery of clinical trials in rare childhood central nervous system (CNS) tumours: a multi-stakeholder consensus

罕见儿童中枢神经系统(CNS)肿瘤临床试验交付的战略路线图:一项多利益相关方共识

2026-08-220
OAAI
Paediatric therapeutic development workshop on medulloblastoma

儿童髓母细胞瘤治疗开发研讨会

2026-07-090
OA
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study

MYC家族扩增型髓母细胞瘤的分子和临床异质性与生存结局相关: 一项多中心队列研究

2024-10-080
OAAI
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma
2024-10-080
OAAI
MOLECULAR PATHOLOGY, TREATMENT AND PROGNOSIS OF INFANT SONIC HEDGEHOG MEDULLOBLASTOMA: A GLOBAL MULTI-COHORT STUDY

婴儿声波刺猬髓母细胞瘤的分子病理学,治疗和预后: 一项全球多队列研究

2024-06-180
OAAI
SIOPE-MB6-THE RATIONALE FOR THE NEXT EUROPEAN STANDARD RISK MEDULLOBLASTOMA PHASE II/III TRIAL

下一个欧洲标准风险髓母细胞瘤II/III期试验的SIOPE-MB6-THE理由

2024-06-180
OAAI
TOWARDS CLINICAL IMPLEMENTATION OF LIQUID BIOPSY ANALYSIS FOR PAEDIATRIC BRAIN TUMOUR PATIENTS - A PAN-EUROPEAN EFFORT FOR STANDARDIZATION
2024-06-180
OAAI
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial

后颅窝脑肿瘤患儿幸存者特定领域神经认知结局的危险因素-HIT 2000试验的结果

2024-06-051
PRE
Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups

髓母细胞瘤的代谢物谱,用于分子疾病组的快速和无创检测

2024-02-012
OAAI
Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage
2024-01-080
OAAI